@article{583987ee59ab48edb9c4bfdc6af5c933,
title = "Zinpentraxin Alfa for Idiopathic Pulmonary Fibrosis: The Randomized Phase III STARSCAPE Trial",
keywords = "Antifibrotic medication, Forced vital capacity (FVC), Futility analysis, Interstitial lung disease, Linear mixed-effects model, Antifibrotic medication, Forced vital capacity (FVC), Futility analysis, Interstitial lung disease, Linear mixed-effects model",
author = "Luca Richeldi and Courtney Schiffman and J{\"u}rgen Behr and Yoshikazu Inoue and Corte, \{Tamera J.\} and Vincent Cottin and Jenkins, \{R. Gisli\} and Nathan, \{Steven D.\} and Ganesh Raghu and Walsh, \{Simon L.F.\} and Jayia, \{Parminderjit K.\} and Nikhil Kamath and Martinez, \{Fernando J.\}",
year = "2024",
doi = "10.1164/rccm.202401-0116oc",
language = "English",
pages = "1--10",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
}